Patent ID: 9737596
Date: 2017-08-22
CPC Classifications: A61K,A61P

Claim:
1. A method of preventing breast cancer recurrence in a subject comprising: administering to the subject a composition in an amount effective to prevent breast cancer recurrence, wherein the composition comprises a pharmaceutically effective carrier, a peptide consisting of the amino acid sequence SEQ ID NO:2 (GP2) and granulocyte macrophage-colony stimulating factor, wherein, other than the peptide consisting of the amino acid sequence of SEQ ID NO:2 (GP2), the composition does not contain any other Her2/neu-derived peptides; wherein prior to the administering step, the subject is in remission following treatment with a standard course of therapy, and wherein the subject is selected to be administered the composition because cancer cells from the subject prior to remission had a high expression of HER2, and wherein the high expression of HER2 is an immunohistochemistry (IHC) rating of 3 + or a fluorescence in situ hybridization (FISH) rating of about 2.0 or greater for HER2/neu gene expression.